Skip to main content
Home

Top menu InfoLep

  • About InfoLep


Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2023
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Practical materials
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Refine your results

Refine your results


NTD

  • Leprosy (Hansen disease) (54)
  • Lymphatic filariasis (Elephantiasis) (5)
  • Buruli Ulcer (4)
  • Trachoma (4)
  • Leishmaniasis (2)
  • Onchocerciasis (2)
  • Schistosomiasis (1)

Country

  • India (16)
  • Nepal (8)
  • Netherlands (7)
  • United States (7)
  • Indonesia (4)
  • Switzerland (4)
  • Germany (3)
  • Thailand (3)
  • United Kingdom (3)
  • Bangladesh (2)
  • Canada (2)
  • Belgium (1)
  • France (1)
  • Italy (1)
  • Myanmar (Burma) (1)
  • New Zealand (1)
  • Portugal (1)
  • Spain (1)

Type of Organization

  • NGO (48)
  • ILEP member (10)
  • Infolep Partner (9)
  • Hospital/clinic (8)
  • People's organization (8)
  • NTD NGDO Network member (7)
  • Training/education (7)
  • Academic/research institution (6)
  • InfoNTD Partner (5)
  • Government department/organization (4)
  • Information, library and publishing (4)
  • Partnership (3)
  • Professional organization (2)
  • Funding & Grants (1)
 
66 items
Organization

AIFO - Associazione Italiana Amici di Raoul Follereau

Organization

ALERT India - Association for Leprosy Education, Rehabilitation and Treatment

Organization

ALM - American Leprosy Missions

Organization

APAL - Association of People Affected by Leprosy

Organization

APARF - Associação Portuguesa Amigos de Raoul Follereau

Organization

APCD Foundation - Asia-Pacific Development Center on Disability

Organization

BIKASH Nepal

Organization

Bogura Federation

Organization

CBM Global

Organization

CLTRI - Central Leprosy Teaching and Research Institute

Organization

DAHW - Deutsche Lepra- und Tuberkulosehilfe e. V.

Organization

DAPA - Disadvantaged People’s Association

Organization

DFIT - Damien Foundation India Trust

Organization

Damien Foundation / Action Damien / Damiaanactie

Organization

Enablement

Organization

Evangelische Lepra-Mission / Mission Évangélique contre la lèpre

Organization

Eye Care Foundation

Organization

FAIRMED - Gesundheit für die Ärmsten / Health for the Poorest.

Organization

FRF - Fondation Raoul Follereau

Organization

Fontilles

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page ›› ›
  • Last page Last » »

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2023 InfoNTD